Complex roles of cAMP–PKA–CREB signaling in cancer
H Zhang, Q Kong, J Wang, Y Jiang, H Hua - Experimental hematology & …, 2020 - Springer
Cyclic adenosine monophosphate (cAMP) is the first discovered second messenger, which
plays pivotal roles in cell signaling, and regulates many physiological and pathological …
plays pivotal roles in cell signaling, and regulates many physiological and pathological …
Subcellular organization of the cAMP signaling pathway
M Zaccolo, A Zerio, MJ Lobo, C Garland - Pharmacological reviews, 2021 - Elsevier
The field of cAMP signaling is witnessing exciting developments with the recognition that
cAMP is compartmentalized and that spatial regulation of cAMP is critical for faithful signal …
cAMP is compartmentalized and that spatial regulation of cAMP is critical for faithful signal …
cAMP signaling in cancer: a PKA-CREB and EPAC-centric approach
Cancer is one of the most common causes of death globally. Despite extensive research
and considerable advances in cancer therapy, the fundamentals of the disease remain …
and considerable advances in cancer therapy, the fundamentals of the disease remain …
Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets
MR Paul, T Pan, DK Pant, NNC Shih… - The Journal of …, 2020 - Am Soc Clin Investig
Nearly all breast cancer deaths result from metastatic disease. Despite this, the genomic
events that drive metastatic recurrence are poorly understood. We performed whole-exome …
events that drive metastatic recurrence are poorly understood. We performed whole-exome …
Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
R Kamel, J Leroy, G Vandecasteele… - Nature Reviews …, 2023 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) modulate the neurohormonal regulation of
cardiac function by degrading cAMP and cGMP. In cardiomyocytes, multiple PDE isozymes …
cardiac function by degrading cAMP and cGMP. In cardiomyocytes, multiple PDE isozymes …
The molecular biology of phosphodiesterase 4 enzymes as pharmacological targets: an interplay of isoforms, conformational states, and inhibitors
Abstract The phosphodiesterase 4 (PDE4) enzyme family plays a pivotal role in regulating
levels of the second messenger cAMP. Consequently, PDE4 inhibitors have been …
levels of the second messenger cAMP. Consequently, PDE4 inhibitors have been …
Gαs–Protein kinase a (PKA) pathway signalopathies: the emerging genetic landscape and therapeutic potential of human diseases driven by aberrant Gαs-PKA …
Many of the fundamental concepts of signal transduction and kinase activity are attributed to
the discovery and crystallization of cAMP-dependent protein kinase, or protein kinase A …
the discovery and crystallization of cAMP-dependent protein kinase, or protein kinase A …
[HTML][HTML] Signal transduction in primary cilia–analyzing and manipulating GPCR and second messenger signaling
The primary cilium projects from the surface of most vertebrate cells, where it senses
extracellular signals to regulate diverse cellular processes during tissue development and …
extracellular signals to regulate diverse cellular processes during tissue development and …
The complexity and multiplicity of the specific cAMP phosphodiesterase family: PDE4, open new adapted therapeutic approaches
C Lugnier - International Journal of Molecular Sciences, 2022 - mdpi.com
Cyclic nucleotides (cAMP, cGMP) play a major role in normal and pathologic signaling.
Beyond receptors, cyclic nucleotide phosphodiesterases;(PDEs) rapidly convert the cyclic …
Beyond receptors, cyclic nucleotide phosphodiesterases;(PDEs) rapidly convert the cyclic …
Cardiac overexpression of PDE4B blunts β-adrenergic response and maladaptive remodeling in heart failure
S Karam, JP Margaria, A Bourcier, D Mika, A Varin… - Circulation, 2020 - Am Heart Assoc
Background: The cyclic AMP (adenosine monophosphate; cAMP)-hydrolyzing protein
PDE4B (phosphodiesterase 4B) is a key negative regulator of cardiac β-adrenergic receptor …
PDE4B (phosphodiesterase 4B) is a key negative regulator of cardiac β-adrenergic receptor …